Daniel Carlat, MD

The Strange Side of Antidepressants

Fun facts from the upcoming Medication Fact Book, 8th Edition

May 23, 2025

Daniel Carlat, MD

Benzos: Misunderstood, Misused — but Sometimes Just Right.

May 22, 2025

Daniel Carlat, MD

"The only thing that works for me is Xanax." "Can I get a 3-month script for Klonopin? My last doc didn't mind."
We’ve all heard versions of these.

FDA Clears First Alzheimer's Blood Test—What's Actually New Here?

May 21, 2025

Daniel Carlat, MD

This week, the FDA cleared the first blood test for Alzheimer’s disease: the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio.It sounds like a big step forward. Maybe it will prove to be one. But after 22 years of Carlat Report coverage of overhyped tests and treatments, I’ve learned to pause before celebrating “firsts.”

Choosing ADHD Meds: A 3 Minute Overview

May 21, 2025

Daniel Carlat, MD

ADHD pharmacology can feel overwhelming. Dozens of formulations. Conflicting data. High stakes for outcomes—and side effects. Each chapter of our Medication Fact Book starts with general tips, and I’m revising the ADHD section for our 8th edition.

CLINICAL UPDATE

Social Anxiety Disorder: Diagnosis and Treatment

January 10, 2025

Daniel Carlat, MD

Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.

Dr. Carlat provides an array of treatments for social anxiety disorder, from SSRIs to psychotherapy,

CLINICAL UPDATE

Treating Bipolar Disorder With Interpersonal and Social Rhythm Therapy

December 18, 2024

Daniel Carlat, MD

Daniel Carlat, MD. Vice Chair, Community and Public Sector Psychiatry, Tufts University School of Medicine. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.

Meds are essential for treating bipolar disorder, but recovery requires more. Interpersonal and Social Rhythm Therapy (IPSRT) empowers patients to stabilize daily routines and strengthen relationships. Here's how it works.

Clinical Guidance

Liver Impairment: Prescribing Psychiatric Medications

November 26, 2024

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Prescribing psychiatric medications for patients with liver impairment is a complex task, given the liver’s critical role in drug metabolism.

Clinical Guidance

Kidney Impairment: Prescribing Psychiatric Medications

November 26, 2024

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Most psychotropic medications can be used safely in patients with kidney disease, although you will need to adjust doses in some cases.

Clinical Guidance

Confusion and Delirium: Psychiatric Evaluation for Consult Liaison Clinicians

November 26, 2024

Daniel Carlat, MD

Dr. Carlat has no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The terms “confusion,” “delirium,” “encephalopathy,” and “altered mental status (AMS)” are often used interchangeably when describing a patient who has undergone a rapid cognitive change and is unable to think and concentrate normally.

Clinical Guidance

Psychiatric Admission Notes: Structure and Key Elements

November 26, 2024

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Admission notes are intended to provide a succinct summary of why the patient is hospitalized, their mental status, the diagnosis, and the initial treatment plan.